DE602007012531D1 - Azabicycloä3.1.0ühexanderivate als modulatoren von dopamin-d3-rezeptoren - Google Patents

Azabicycloä3.1.0ühexanderivate als modulatoren von dopamin-d3-rezeptoren

Info

Publication number
DE602007012531D1
DE602007012531D1 DE602007012531T DE602007012531T DE602007012531D1 DE 602007012531 D1 DE602007012531 D1 DE 602007012531D1 DE 602007012531 T DE602007012531 T DE 602007012531T DE 602007012531 T DE602007012531 T DE 602007012531T DE 602007012531 D1 DE602007012531 D1 DE 602007012531D1
Authority
DE
Germany
Prior art keywords
dopamine
modulators
receptors
oxide derivatives
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007012531T
Other languages
English (en)
Inventor
Barbara Bertani
Fabrizio Micheli
Alessandra Pasquarello
Silvia Terreni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0607896A external-priority patent/GB0607896D0/en
Priority claimed from GB0703387A external-priority patent/GB0703387D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE602007012531D1 publication Critical patent/DE602007012531D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE602007012531T 2006-04-03 2007-03-30 Azabicycloä3.1.0ühexanderivate als modulatoren von dopamin-d3-rezeptoren Active DE602007012531D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0607896A GB0607896D0 (en) 2006-04-03 2006-04-03 Novel compounds
GB0703387A GB0703387D0 (en) 2007-02-21 2007-02-21 Novel compounds
PCT/EP2007/053115 WO2007113258A1 (en) 2006-04-03 2007-03-30 Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors

Publications (1)

Publication Number Publication Date
DE602007012531D1 true DE602007012531D1 (de) 2011-03-31

Family

ID=38109652

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007012531T Active DE602007012531D1 (de) 2006-04-03 2007-03-30 Azabicycloä3.1.0ühexanderivate als modulatoren von dopamin-d3-rezeptoren

Country Status (5)

Country Link
US (1) US8163927B2 (de)
EP (1) EP2010518B1 (de)
AT (1) ATE498619T1 (de)
DE (1) DE602007012531D1 (de)
WO (1) WO2007113258A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200870404A1 (ru) 2006-04-03 2009-04-28 Глэксо Груп Лимитед Производные азабицикло[3.1.0.]гексила в качестве модуляторов рецепторов допамина d3
KR20120106697A (ko) 2009-06-26 2012-09-26 파나세아 바이오테크 리미티드 신규 아자비시클로헥산
US11447484B2 (en) 2018-01-26 2022-09-20 Shionogi & Co., Ltd. Cyclic compound having dopamine D3 receptor antagonistic effect
ES2910071T3 (es) 2018-03-08 2022-05-11 Incyte Corp Compuestos de aminopirazina diol como inhibidores de PI3K-Y
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015562D0 (en) * 2000-06-23 2000-08-16 Pfizer Ltd Heterocycles
ATE451364T1 (de) 2004-02-23 2009-12-15 Glaxo Group Ltd Als modulatoren des dopamin-d3-rezeptors geeignete azabicycloä3.1.0ühexanderivate
GB0507601D0 (en) 2005-04-14 2005-05-18 Glaxo Group Ltd Compounds
GB0507602D0 (en) * 2005-04-14 2005-05-18 Glaxo Group Ltd Compounds
GB0507680D0 (en) 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
GB0512099D0 (en) 2005-06-14 2005-07-20 Glaxo Group Ltd Compounds
JP5068747B2 (ja) 2005-06-14 2012-11-07 グラクソ グループ リミテッド ドーパミンd3受容体のモジュレーターとしてのアザビシクロ[3.1.0]ヘキサン誘導体
GB0517193D0 (en) 2005-08-22 2005-09-28 Glaxo Group Ltd Novel use
ATE487715T1 (de) 2005-08-22 2010-11-15 Glaxo Group Ltd Triazolderivate als modulatoren von dopamin-d3- rezeptoren
GB0517175D0 (en) 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
GB0517187D0 (en) 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
GB0517191D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
EA200870404A1 (ru) 2006-04-03 2009-04-28 Глэксо Груп Лимитед Производные азабицикло[3.1.0.]гексила в качестве модуляторов рецепторов допамина d3
GB0616574D0 (en) 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
US20100063097A1 (en) 2010-03-11
EP2010518B1 (de) 2011-02-16
ATE498619T1 (de) 2011-03-15
EP2010518A1 (de) 2009-01-07
WO2007113258A1 (en) 2007-10-11
US8163927B2 (en) 2012-04-24

Similar Documents

Publication Publication Date Title
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
CR10138A (es) 1h indoles sustituidos por sulfonilo como ligandos para los receptores 5-hidroxitriptamina
ATE478072T1 (de) Spiroimidazol-derivate als ppar-modulatoren
ATE449097T1 (de) Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
ECSP067121A (es) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
ECSP11010885A (es) Heteroarilos sustituidos
ECSP067120A (es) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas
MX2007011023A (es) 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3.
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
SV2011003809A (es) Derivados de heteroarilo como inhibidores de dgat1
NO20061845L (no) Fenyl-piperazinderivater som modulatorer for muskarine reseptorer
EA201100037A1 (ru) Органические соединения
BRPI0818672A2 (pt) 2'-fluor-2'-desoxitetra-hidrouridinas como inibidores da citidina desaminase
EA200601895A1 (ru) 3-(4-гетероарилциклогексиламино)циклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
NO20084007L (no) Spirokondenserte piperidiner som modulatorer av muskarinreseptorer
UA94749C2 (en) Benzimidazole modulators of vr1
ATE537170T1 (de) Cgrp-rezeptorantagonisten
UY30052A1 (es) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas
DK1948606T3 (da) 3, 5-disubstituerede phenyl-piperidiner som modulatorer af dopaminneurotransmission
CY1112683T1 (el) Υποκατεστημενες καρβοξαμιδες ν-φαινυλ-διπυρρολιδινης και θεραπευτικες χρησεις τους
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
DE602006012694D1 (de) Benzimidazolthiophenverbindungen als plk-modulatoren
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
ATE421518T1 (de) Dihydrochinazolinone als 5ht-modulatoren